EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSBTAG00000007375
Gene Symbol: MIF
5 Enzyme and pathways 5 Cross references
230 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSBTAG00000015046
Gene Symbol: MST1R
3 Enzyme and pathways 5 Cross references
280 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSBTAG00000046152
Gene Symbol: MGAM
6 Enzyme and pathways 5 Cross references
324 Possible Orthologues:

Mast Cell Protease 2

Ensembl ID : ENSBTAG00000050871
Gene Symbol: LOC100139881
9 Enzyme and pathways 4 Cross references
319 Possible Orthologues:

Mast Cell Protease 2

Ensembl ID : ENSBTAG00000052449
Gene Symbol: LOC540321
4 Cross references
320 Possible Orthologues:

Matrix Metallopeptidase 1 (Interstitial Collagenase)

Ensembl ID : ENSBTAG00000048029
Gene Symbol: MMP1
4 Enzyme and pathways 4 Cross references
346 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSBTAG00000053542
Gene Symbol: MMP12
3 Enzyme and pathways 5 Cross references
572 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSBTAG00000015059
Gene Symbol: MMP13
4 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSBTAG00000014824
Gene Symbol: MMP14
4 Enzyme and pathways 5 Cross references
284 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSBTAG00000019267
Gene Symbol: MMP2
13 Enzyme and pathways 5 Cross references
222 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSBTAG00000037768
Gene Symbol: MMP3
8 Enzyme and pathways 4 Cross references
514 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSBTAG00000004594
Gene Symbol: MMP7
8 Enzyme and pathways 5 Cross references
175 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).